| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 6, 2015Virtual Press Office and PR Newswire: General Trade show news
For ten days – from September 17 to 27 – visitors to the Opel booth at IAA 2015 could create their own personal 'Opel Selfie Jump' – a Bullet-Time tracking shot with solutions provided by...
-
Nov 6, 2015Virtual Press Office and PR Newswire: General Trade show news
NextEra Energy, Inc. (NYSE: NEE) and NextEra Energy Partners, LP (NYSE: NEP) will participate in the EEI Financial Conference from Sunday, Nov. 8, 2015, through Tuesday, Nov. 10, 2015, as well as...
-
Nov 6, 2015Virtual Press Office and PR Newswire: General Trade show news
UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is presenting 19 studies of CIMZIA® (certolizumab pegol) and investigational medicines for...
-
Nov 6, 2015Virtual Press Office and PR Newswire: General Trade show news
RPM International Inc. (NYSE: RPM) announced today that Russell L. Gordon, vice president and chief financial officer, will present at the 4th Annual Morgan Stanley Global Chemicals & Agriculture...
-
Nov 6, 2015NAIAS - North American International Auto Show News
The North American International Auto Show (NAIAS) announced today that online media registration is now open for Press Preview for the upcoming 2016 auto show, Jan. 11-12 at Cobo Center in...
-
Nov 6, 2015Virtual Press Office and PR Newswire: General Trade show news
MDC Partners Inc. (NASDAQ: MDCA; TSX: MDZ.A) ("MDC Partners" or the "Company") announced today that Scott Kauffman, Chairman and Chief Executive Officer, and David Doft, Chief Financial Officer,...
-
Nov 6, 2015Virtual Press Office and PR Newswire: General Trade show news
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Nov 6, 2015Virtual Press Office and PR Newswire: General Trade show news
Rhythm Pharmaceuticals, Inc. announced today the results from a proof-of-concept, Phase 1b clinical trial assessing the safety and efficacy of setmelanotide (RM-493), the company's novel...
-
Nov 6, 2015Virtual Press Office and PR Newswire: General Trade show news
Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced the presentation of clinical data featuring the use of its Precision Cancer MonitoringSM (PCM) platform...
-
Nov 6, 2015Virtual Press Office and PR Newswire: General Trade show news
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY) today announced that top-line renal results from the EMPA-REG OUTCOME® study (compound empagliflozin,...
